期刊文献+

人类免疫缺陷病毒与深部真菌感染 被引量:2

Human immunodeficiency virus and deep fungal infection
下载PDF
导出
摘要 人类免疫缺陷病毒(HIV)感染的发病率与致死率很高,已成为人类健康的一大威胁,其中约50%的HIV感染者最终因侵袭性真菌病而死亡。高效抗反转录病毒治疗(HAART)的应用大大降低了HIV感染者深部真菌病的发生率。因此,深入研究HIV与深部真菌病的关系,对预防、诊断和治疗HIV感染者深部真菌病具有十分重要的意义。本文归纳了HIV感染者深部真菌病的流行病学调查、诊断与治疗进展,有助于临床医师预防和诊治HIV感染者深部真菌病,也为将来新型抗真菌药物的研发提供了思路和方向。 Human immunodeficiency virus (HIV ) is a global threat to health with high morbidity and mortality ,and 50% of all HIV‐related death is associated with invasive fungal infection . Highly active antiretroviral therapy (HAART ) is used to treat HIV infection and can significantly reduce incidence of HIV‐related opportunistic fungal infection .In this article ,the epidemiology ,diagnosis and treatment of HIV‐related fungal infection are reviewed , giving an insight into study of deep fungal infection and a reference for clinic practice .
出处 《微生物与感染》 2015年第3期134-139,共6页 Journal of Microbes and Infections
基金 国家重点基础研究发展计划(2013CB531601-06) 国家"十二五"科技重大专项(2013ZX10004612-001) 上海市科委重点实验室建设项目(14DZ2272900)
关键词 人类免疫缺陷病毒 深部真菌病 流行病学 抗真菌药物 Human immunodeficiency virus Deep fungal infection Epidemiology Antifungal drug
  • 相关文献

参考文献39

  • 1Armstrong-James DM, Brown GD. A neglected epidemic: fungal infections in HIV/AIDS [ J ]. Trends Microbiol, 2014, 22(3): 120-127.
  • 2Mayer KH, Auwaerter PG. Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogens ]. Clin Infect Dis, 2007, 45(9) : 1208-1213.
  • 3Gullo FP, Rossi SA, Sardi Jde C, Teodoro VL, Mendes- Giannini M J, Fusco-Almeida AM. Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment [J]. Eur J Clin Microbiol Infect Dis, 2013, 32 (Ii) : 1377-1391.
  • 4Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS ]. AIDS, 2009, 23(4): 525-530.
  • 5Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodefieiency virus infection [J]. N Engl J Med, 1998, 338(13) : 853-860.
  • 6Antinori S, Galimberti L, Magni C, Casella A, Vago L, Mainini F, Piazza M, Nebuloni M, Fasan M, Bonaccorso C, Vigevani GM, Cargnel A, Moroni M, Ridolfo A. Cryptococcus neoformans infection in a cohort of Italian AIDS patients., natural history, early prognostic parameters, and autopsy findings [J]. Eur J Clin Microbiol Infect Dis, 2001, 20(10): 711-717.
  • 7Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, Holmberg S, Jones JL. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy [J]. Clin Infect Dis, 2900, 30 (1) $5-$14.
  • 8Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, Gardner T, Sattah M, de Leon GP, Baughman W, Hajjeh RA. The changing epidemiology of cryptococcosis., an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000 [J]. Clin Infect Dis, 2003, 36(6) : 789-794.
  • 9Dromer F, Mathoulin-P61issier S, Fontanet A, Ronin O, Dupont B, Lortholary O; French Cryptococcosis Study Group. Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post- HAART eras [J]. AIDS, 2004, 18(3): 555-562.
  • 10Michaels SH, Kissinger P. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection ]. N Engl J Med, 1998, 339(6) : 405-406.

同被引文献28

  • 1赵明,顾新伟,李民,范礼佩,岳良升,郭颖,黄先恩.肾移植术后感染性移植肾动脉破裂六例报告[J].中华泌尿外科杂志,2005,26(1):32-32. 被引量:13
  • 2Sherman KE, Terrault N, Barin B, Rouster SD, Shata MT; HIV-TR Investigators. Hepatitis E infection in HIV- infected liver and kidney transplant candidates [J]. J Viral Hepat, 2014, 21(8).. e74-e77.
  • 3Kuniholm MH, Ong E, Hogema BM, Koppelman M, Anastos K, Peters MG, Seaberg EC, Chen Y, Nelson KE, Linnen JM. Acute and chronic hepatitis E virus infection in HIV-infected U.S. women [J]. Hepatology, 2016, 63(3): 712-720.
  • 4Geng Y, Zhao C, Huang W, Harrison TJ, Zhang H, Geng K, Wang Y. Detection and assessment of infectivity of hepatitis E virus in urine [J]. J Hepatol, 2016, 64(1): 37-43.
  • 5Geng , Zhang H, Huang W, Harrison TJ, Geng K, Li Z, Wang Y. Persistent hepatitis E virus genotype 4 infection in a child with acute lymphoblastic leukemia E J/OLd. Hepat Mon, 2014. http://www, ncbi. nlm. nih. gov/pmc/ articles/PMC3929864.
  • 6Kamar N, Rostaing L, Izopet J. Hepatitis E virus infection in immunosuppressed patients: natural history and therapy [J]- Semin Liver Dis, 2013, 33(1): 62-70.
  • 7Cleland A, Smith L, Crossan C, Blatchford O, Dalton HR, Scobie L, Petrik J. Hepatitis E virus in Scottish blood donors [J]. Vox Sang, 2013, 105(4).. 283-289.
  • 8Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ, Wang H, Jiang HM, Wang YJ, Yan Q, Guo M, Liu XH, Li JX, Yang CL, Tang Q, Jiang RJ, Pan HR, Li YM, Shih JW, Ng MH, Zhu FC, Xia NS. Long-term efficacy of a hepatitis E vaccine [J]. N Engl J Med, 2015, 372(10) .. 914- 922.
  • 9Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP, Wang YJ, Ai X, Hu YM, Tang Q, Yao X, Yan Q, Xian YL, Wu T, Li YM, Miao J, Ng MH, Shih JW, Xia NS. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults, a large-scale, randomised, double-blind placebo- controlled, phase 3 trial [J]. Lancet, 2010, 376 (9744) 895-902.
  • 10Zhang J, Li SW, Wu T, Zhao Q, Ng MH, Xia NS. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity [J]. Rev Med Virol, 2012, 22 (5): 339-349.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部